Cargando…
High-dose chemotherapy in a patient with coronavirus disease (COVID-19)
Autores principales: | De Giorgi, Ugo, Casadei, Chiara, Bronte, Giuseppe, Altini, Mattia, Martinelli, Giovani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334969/ https://www.ncbi.nlm.nih.gov/pubmed/32683272 http://dx.doi.org/10.1016/j.ejca.2020.06.026 |
Ejemplares similares
-
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy
por: Cursano, Maria Concetta, et al.
Publicado: (2020) -
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2023) -
Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours
por: De Giorgi, U, et al.
Publicado: (2005) -
Current laboratory diagnostics of coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020) -
CAR-T cell therapy: a potential new strategy against prostate cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2019)